project id: TCGA-BRCA; case submitter id: TCGA-C8-A1HL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 10.0; spectrophotometer method: UV Spec; age at index: 38; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1972; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 317.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 94; days to sample procurement: 0; initial weight: 980.0; portion submitter id: TCGA-C8-A1HL-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;